28
Oct
2025

Cayman Pharma s.r.o

Exhibitor at CPHI Frankfurt 2025 stand 11.1F56, API
About Us

Cayman Pharma is the world’s most reliable source of prostaglandin Active Pharmaceutical Ingredients (APIs) using its own patented route to manufacture APIs for ophthalmic, veterinary, vascular, and psychedelic applications. Cayman Pharma has an excellent track record and an outstanding record of regulatory compliance. Together with Cayman Chemical Company, Cayman Pharma represents the accumulation of almost 60 years of experience with prostaglandin synthesis.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CZ
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 11.1F56, API

Products Featured at CPHI Frankfurt 2025

  • CGMP (+)-Cloprostenol (sodium salt)

    Product CGMP (+)-Cloprostenol (sodium salt)

    (+)-Cloprostenol is the active enantiomer of Cloprostenol. Cloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. The ASMF for (+)-Cloprostenol (sodium salt) is on file in several EU member states.
  • CGMP Bimatoprost

    Product CGMP Bimatoprost

    Bimatoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. The DMF is on file with the US FDA, Brazil, Canada and India.
  • CGMP Epoprostenol sodium salt

    Product CGMP Epoprostenol sodium salt

    Epoprostenol is a potent vasodilator and antiplatelet substance with a very short physiological half-life. It is used for the treatment of pulmonary hypertension. The DMF for Epoprostenol Sodium Salt is on file with the US FDA, Canada, Japan, Australia, Switzerland and most EU member states.
  • CGMP Cloprostenol sodium salt

    Product CGMP Cloprostenol sodium salt

    Cloprostenol sodium salt is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. Cloprostenol sodium salt is manufactured at Cayman Pharma both in racemic form (CAS No.: 55028-72-3) and optically active form ...
  • CGMP Latanoprost

    Product CGMP Latanoprost

    Latanoprost is the most widely used prostaglandin for the treatment of elevated intraocular pressure in glaucoma. Latanoprost is manufactured at Cayman Chemical (Ann Arbor, MI, USA) and at Cayman Pharma (Czech Republic). GMP material from both Cayman Chemical and Cayman Pharma, which conforms to the USP, E...
  • CGMP Latanoprostene Bunod

    Product CGMP Latanoprostene Bunod

    Latanoprostene Bunod is a nitric oxide-donating FP receptor agonist; it can be used for the treatment of elevated intraocular pressure (IOP) in glaucoma. Latanoprostene Bunod is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF for Latanoprostene Bunod is available...
  • CGMP Psilocin

    Product CGMP Psilocin

    Psilocin is the active form of Psilocybin, a naturally occurring psychedelic prodrug produced by more than 200 species of fungi. Psilocin is manufactured at Cayman Chemical in Ann Arbor, MI via a fully synthetic route. GMP material appropriate for clinical trials is available.
  • CGMP Psilocybin

    Product CGMP Psilocybin

    Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. Synthetic and natural forms of psilocybin are currently being studied in numerous clinical trials for the treatment of depression, anxiety, and other mental health conditions. Psilocybin is ...